KOSDAQChemicals101240

CQV

₩2,790▼ 1.24%2026-11-18 close
Market Cap
₩31.7B
Turnover
₩29,667,570
Volume
10K
Shares out.
11.4M
PER
4.6×
PBR
0.3×
EPS
₩683
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

CQV: Quarterly Profit Recovers, Then a Q3 2026 Net Loss

CQV held operating profit at KRW 10.2 billion in both 2024 and 2025 and lifted quarterly operating profit sharply in the first two quarters of 2026, but Q3 2026 brought a KRW 1.49 billion net loss attributable to controlling shareholders.

  1. 1

    Annual sales peaked at KRW 60.1 billion in 2024 and fell 6.0% to KRW 56.5 billion in 2025, yet operating profit stayed at KRW 10.2 billion.

  2. 2

    Net income attributable to controlling shareholders bottomed at KRW 3.43 billion in 2023, rose in both 2024 and 2025, and reached KRW 9.45 billion in 2025.

  3. 3

    Quarterly operating profit was KRW 3.02 billion in Q1 2026, KRW 5.54 billion in Q2 and KRW 2.59 billion in Q3, while Q3 turned into a KRW 1.49 billion net loss attributable to controlling shareholders.

  4. 4

    The largest shareholder and related parties hold 50.87% combined, and parent GNMI said in August 2025 that it had completed the acquisition of Merck's Surface Solution business (SuSo).

  5. 5

    The debt ratio was 22.6% at end-2025, and all KRW 115.5 billion of total equity is attributable to controlling shareholders.

02

Business structure

CQV is known as a KOSDAQ chemicals company whose core business is pearlescent pigments, with automotive applications as its main line. Based on the 2Q 2026 sales mix compiled by data platform Butler, automotive accounted for 45%, cosmetics 35%, industrial 20%, and aluminum paste and others 1%.

Automotive and cosmetics together make up 80% of sales, so order flows in those two industries pass quickly into revenue.

The company is building colored aluminum and aluminum paste as new businesses to respond to home appliance market trends, and is developing products that combine pearlescent and aluminum paste technologies.

Total holdings of the largest shareholder and related parties stand at 50.87%, with the latest change recorded on October 1, 2025. The parent is GNMI, which also has a strategic business alliance with CQV.

In August 2025 GNMI said it had completed the acquisition of Merck's Surface Solution business (SuSo) for a total price of EUR 665 million, roughly KRW 1 trillion. The acquired unit was renamed SUSONITY and became a wholly owned subsidiary of GNMI.

The company expects the deal to complete a portfolio from low-priced to ultra-premium products and to widen its global sales network and production footprint. How much of this shows up in CQV's own sales mix is a point to confirm in the 2026 annual report's segment disclosure.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩14B₩2.3B16.3%
2025Q4₩11.8B₩1.5B12.6%
2026Q1₩15.8B₩3B19.2%
2026Q2₩20.2B₩5.5B27.4%
2026Q3₩15.4B₩2.6B16.8%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩46.3B₩6.5B₩5.4B14.1%8.3%33.2%
2023₩51.1B₩5B₩3.4B9.8%4.4%19.6%
2024₩60.1B₩10.2B₩9.3B17.0%10.5%30.9%
2025₩56.5B₩10.2B₩9.5B18.0%8.2%22.6%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-16

04

Earnings analysis

Annual sales rose from KRW 46.3 billion in 2022 to KRW 51.1 billion in 2023 (up 10.4% year on year) and KRW 60.1 billion in 2024 (up 17.7%), then fell 6.0% to KRW 56.5 billion in 2025. Across 2022 to 2025, 2024 was the largest year and 2022 the smallest.

Operating profit fell from KRW 6.51 billion in 2022 to KRW 5.03 billion in 2023 (down 22.7%), then more than doubled to KRW 10.2 billion in 2024 (up 103.0%) and held nearly flat in 2025 (down 0.4%).

The operating margin was 14.1% in 2022, 9.8% in 2023, 17.0% in 2024 and 18.0% in 2025, so it rose in 2025 even as sales declined. The drivers behind that margin change are a point to check in the annual report's segment and product explanations.

Net income attributable to controlling shareholders was KRW 5.38 billion in 2022, KRW 3.43 billion in 2023 (down 36.4%), KRW 9.26 billion in 2024 (up 170.5%) and KRW 9.45 billion in 2025 (up 2.0%), rising in 2024 and 2025 after the 2023 low.

Net income including non-controlling interests was reported at the same yearly amounts. Operating cash flow was KRW 9.89 billion in 2022, KRW 9.03 billion in 2023, KRW 13.5 billion in 2024 and KRW 10.2 billion in 2025, peaking in 2024. The debt ratio fell to 22.6% at end-2025 from 30.9% in 2024.

Quarterly sales dropped to KRW 11.8 billion in Q4 2025 with operating profit of KRW 1.48 billion, before recovering to KRW 15.8 billion in sales and KRW 3.02 billion in operating profit in Q1 2026 (operating profit up 104.0% quarter on quarter).

Q2 2026 sales of KRW 20.2 billion and operating profit of KRW 5.54 billion (up 83.4% quarter on quarter) were the highest of the last five quarters.

Q3 2026 sales were KRW 15.4 billion (down 23.8% quarter on quarter, up 9.6% year on year) and operating profit was KRW 2.59 billion (down 53.2% quarter on quarter), but the company posted a KRW 1.49 billion net loss attributable to controlling shareholders, a swing into loss from a year earlier.

Operating profit remained positive while net results turned negative, so the items below operating profit, including non-operating items and income tax, should be checked in the annual report. Net income attributable to controlling shareholders over the last four quarters (Q4 2025 to Q3 2026) totals KRW 7.6 billion.

05

Industry analysis

Pearlescent pigments are specialty colorants used in automotive paints, cosmetics and plastics, and their demand follows product trends in those customer industries.

On the automotive side, the shift from solid colors toward special-effect shades such as pearl and metallic finishes is cited as a driver of demand for premium paint pigments. In cosmetics, demand for differentiated color and texture in eyeshadow and lip products links directly to pigment demand.

Industrial uses such as plastics and inks are more general-purpose and tend to be more sensitive to economic cycles. CQV is introduced as a leader in automotive pearlescent pigments.

Among listed Korean chemical companies, LG Chem and Hanwha Solutions are centered on petrochemicals and battery materials, so their business structures differ sharply from CQV's.

In global competition, the company says GNMI's acquisition of Merck's surface solutions business could reshape the pearlescent pigment market. Cycle position is usually gauged through customer-industry indicators such as automotive output and cosmetics exports, which need to be checked separately.

06

Outlook

Full-year 2026 results have not yet been filed in a periodic report, and the next periodic report is the 2026 annual report. Quarterly results from Q1 through Q3 2026 are already filed in periodic reports, so they serve as the base for gauging the next earnings.

Sales rose from KRW 15.8 billion in Q1 to KRW 20.2 billion in Q2 and drove the profit recovery, then fell to KRW 15.4 billion in Q3 with operating profit of KRW 2.59 billion.

According to Butler's disclosure list, an extraordinary shareholders' meeting result was disclosed on July 10, 2026, and a disclosure on July 31, 2026 covered the acquisition of convertible bonds before maturity. The specific agenda items and bond terms are points to check in the DART original filings.

Whether the portfolio and production-footprint benefits the company attributes to the Merck SuSo deal appear in CQV's sales mix is also a point to watch.

Whether the automotive share of 45% and cosmetics share of 35% hold, and how much order flow in those two customer groups feeds into quarterly sales, are the key variables for coming quarters.

The 2026 annual report will finalize Q4 operating profit, net results attributable to controlling shareholders, and the non-operating items behind the Q3 net loss. Comparing full-year 2026 operating profit with the 2025 level of KRW 10.2 billion is also a point to confirm.

07

Valuation

PER
4.6×
PBR
0.3×
ROE
7.0%
EPS
₩683
BPS
₩11,351
Dividend per share
₩0

Valuation is best read by looking together at the share price relative to earnings scale and the share price relative to net assets. The price-to-book ratio sits well below 1x, meaning the shares trade at a price lower than book net assets.

The price-to-earnings ratio is calculated on net income attributable to controlling shareholders over the last four quarters, which totals KRW 7.6 billion, so with a Q3 2026 net loss included, the multiple moves sensitively with quarterly results.

The dividend yield is below the industry average (based on fnguide's sector comparison). Against total equity of KRW 115.5 billion at end-2025 and total liabilities of KRW 26.1 billion, the debt burden is low, so earnings trends sit at the center of any valuation comparison.

The operating margin rose to 17.0% in 2024 and 18.0% in 2025, but net results turned to a loss in Q3 2026, so the multiple should be read alongside that change in earnings direction.

With the largest shareholder and related parties holding 50.87% combined, the share of stock available for trading may be relatively small, which can affect where the share price sits.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-16

08

Bull factors

Operating margin resilience

The operating margin climbed from 9.8% in 2023 to 17.0% in 2024 and 18.0% in 2025. Operating profit held at KRW 10.2 billion in 2025 even as sales fell 6.0%, which points to profit resilience. The debt ratio also fell to 22.6% at end-2025 from 30.9% a year earlier.

Quarterly profit recovery in 2026

Operating profit rose 104.0% quarter on quarter to KRW 3.02 billion in Q1 2026, then 83.4% more to KRW 5.54 billion in Q2. Q2 sales of KRW 20.2 billion were the highest of the last five quarters, so the profit recovery came with revenue growth.

Net income attributable to controlling shareholders also climbed to KRW 2.41 billion in Q1 and KRW 4.81 billion in Q2.

Expected global portfolio expansion

GNMI acquired Merck's SuSo business and folded it in as SUSONITY. The company said the deal could complete a portfolio from low-priced to ultra-premium products, and that joint R&D and shared sales networks could lift market share.

Production bases in China, Korea, Germany, Japan and the US were also cited as expected benefits. How much of this shows up in CQV's own results is a point to check in the 2026 annual report.

09

Bear factors

Q3 swing into net loss

Q3 2026 operating profit was KRW 2.59 billion, still positive, but the company posted a KRW 1.49 billion net loss attributable to controlling shareholders. Over the same quarter, sales fell 23.8% and operating profit fell 53.2% quarter on quarter. The loss came from items below operating profit, and the breakdown is to be checked in the 2026 annual report.

Sales volatility and the 2025 decline

Sales fell 6.0% to KRW 56.5 billion in 2025. Q3 2026 sales were up 9.6% year on year but down 23.8% quarter on quarter, and quarterly sales moved between KRW 11.8 billion and KRW 20.2 billion over the last five quarters. Swings this wide make quarter-to-quarter comparisons a poor basis for reading the trend.

Governance and capital events

The largest shareholder and related parties hold 50.87% combined, and parent GNMI's decisions carry weight over business direction and capital policy. Butler's disclosure list shows an extraordinary shareholders' meeting result and an acquisition of convertible bonds before maturity in July 2026. Terms of those bonds and any change in share count are points to check in the DART filings.

10

Risk factors

Earnings volatility

Quarterly operating profit fell from KRW 5.54 billion in Q2 2026 to KRW 2.59 billion in Q3, and net results moved from profit to a loss attributable to controlling shareholders. With the last four quarters totaling KRW 7.6 billion, a swing in one or two quarters can change the annual picture. Whether the Q3 loss stems from non-operating or one-time items changes how it should be read.

Customer industry concentration

Automotive at 45% and cosmetics at 35% add up to 80% of sales, so a slowdown in either industry or inventory adjustments at customers could reach revenue quickly. The 20% industrial segment is tied to plastics and inks, which are more exposed to economic slowdowns. Customer concentration should be checked in the major customer disclosures of the annual report.

Acquisition integration and governance

Because GNMI acquired Merck's SuSo business for EUR 665 million (roughly KRW 1 trillion), how the group integrates the unit and how the deal was financed matter for how it connects with CQV. The terms and transactions under the strategic business alliance between CQV and GNMI should be confirmed in disclosures. Whether the acquired unit falls within the consolidation scope is also a point to confirm.

11

What to watch next

  1. By March 31, 2027

    Filing of the 2026 annual report. Q4 2026 operating profit, net results attributable to controlling shareholders, and the non-operating items and income tax behind the Q3 net loss will be finalized.

  2. Around early 2027 (date not yet set)

    Disclosure of preliminary Q4 and full-year 2026 results. The key check is how full-year 2026 operating profit compares with the KRW 10.2 billion recorded in 2025.

  3. Around March 2027

    Regular shareholders' meeting. This is where dividend decisions and any board changes are confirmed; the dividend yield currently sits below the industry average.

  4. By May 15, 2027

    Filing of the Q1 2027 quarterly report. The check is whether operating profit stays positive after the Q3 2026 swing and whether sales return toward the KRW 20.2 billion level of Q2 2026.

12

Overall view

CQV's sales rose from KRW 46.3 billion in 2022 to KRW 60.1 billion in 2024 and fell to KRW 56.5 billion in 2025, while operating profit held at KRW 10.2 billion in both 2024 and 2025.

The operating margin rose from a 9.8% low in 2023 to 18.0% in 2025, and net income attributable to controlling shareholders rose in both 2024 and 2025.

Quarterly operating profit climbed to KRW 3.02 billion in Q1 2026 and KRW 5.54 billion in Q2, but Q3 2026 operating profit of KRW 2.59 billion was accompanied by a KRW 1.49 billion net loss attributable to controlling shareholders.

Net income attributable to controlling shareholders over the last four quarters totals KRW 7.6 billion.

The business is centered on automotive at 45% and cosmetics at 35%, and with parent GNMI completing its acquisition of Merck's SuSo business in August 2025, product portfolio and global footprint expansion are expected.

Strengths include earnings resilience, a low debt ratio and the acquisition's expected effects, while weaknesses include quarterly earnings volatility, the Q3 2026 swing into loss and concentration in customer industries.

The points to confirm next are the non-operating items and income tax in the 2026 annual report, the scale of sales recovery in the Q1 2027 quarterly report, and how far SuSo is reflected in CQV's consolidated results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 15 more articles and sources
  1. comp.fnguide.com
  2. butler.works
  3. m.finance.daum.net
  4. calculator.io.kr
  5. investing.com
  6. edaily.co.kr
  7. buffettlab.co.kr
  8. edaily.co.kr
  9. kind.krx.co.kr
  10. jobkorea.co.kr
  11. m.news.nate.com
  12. datatooza.com
  13. kind.krx.co.kr
  14. jobkorea.co.kr
  15. tradingkey.com

Report written 2026-11-16 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis